Lynparza (olaparib) tablets, 100mg (YJ code: 4291052F1027, standard: 100mg 1 tablet), manufactured by AstraZeneca, are a PARP inhibitor used to treat certain types of ovarian, breast, pancreatic, and prostate cancers, particularly those with BRCA mutations. It works by preventing cancer cells from repairing damaged DNA, leading to their destruction.
Lynparza tablets 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →